Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Nyla Haque


I am a Clinical Trial Manager working within the Oxford Brain Health Clinical Trials Unit (OBHCTU) where I am responsible for the set-up and oversight of medical technology studies. I am currently setting up the PETRUSHKA study led by Professor Andrea Cipriani, which aims to evaluate a novel decision-making tool which will be used to aid clinicians in prescribing antidepressants. Prior to joining the OBHCTU, I was working within the Translational Neuroscience and Dementia Research Group setting up and managing multi-centre clinical trials and observational studies in Alzheimer's disease, Mild Cognitive Impairment (MCI) and healthy populations. Previous to this, I worked as a Clinical Trial Coordinator within an NHS setting. I was involved in several phase I-III clinical trials investigating novel disease modifying therapies in patients with Alzheimer’s disease. Within my time at the Neuroepidemology & Ageing Unit, Imperial College London, I gained experience of coordinating a large prospective readiness cohort study investigating risk factors of Alzheimer’s disease in healthy participants. While studying for my BSc Psychology degree, I spent my university placement year working in a neurorehabilitation service for adults who had suffered traumatic & acute brain injury.